- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-6269
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Current Advances in Immunotherapy for Glioblastoma ; volume:23 ; number:2 ; day:26 ; month:1 ; year:2021 ; pages:1-18 ; date:2.2021
Current oncology reports ; 23, Heft 2 (26.1.2021), 1-18, 2.2021
- Urheber
-
Mende, Abigail L.
Schulte, Jessica D.
Okada, Hideho
Clarke, Jennifer L.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11912-020-01007-5
- URN
-
urn:nbn:de:101:1-2021040623061485653652
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mende, Abigail L.
- Schulte, Jessica D.
- Okada, Hideho
- Clarke, Jennifer L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Advances in immunotherapy for the treatment of glioblastoma
Current State of Immunotherapy for Treatment of Glioblastoma
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
Current status and recent advances in reirradiation of glioblastoma
Advances on immunotherapy for osteosarcoma
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
Immunotherapy for glioblastoma: the promise of combination strategies
Advances in nano-immunotherapy for hematological malignancies
Advances in predictive biomarkers for melanoma immunotherapy
Natural killer cell immunotherapy in glioblastoma
Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications
Advances in immunotherapy for the treatment of glioblastoma
Current State of Immunotherapy for Treatment of Glioblastoma
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
Current status and recent advances in reirradiation of glioblastoma
Advances on immunotherapy for osteosarcoma
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
Immunotherapy for glioblastoma: the promise of combination strategies
Advances in nano-immunotherapy for hematological malignancies
Advances in predictive biomarkers for melanoma immunotherapy
Natural killer cell immunotherapy in glioblastoma
Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications
Advances in immunotherapy for the treatment of glioblastoma
Current State of Immunotherapy for Treatment of Glioblastoma
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
Current status and recent advances in reirradiation of glioblastoma
Advances on immunotherapy for osteosarcoma
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
Immunotherapy for glioblastoma: the promise of combination strategies
Advances in nano-immunotherapy for hematological malignancies
Advances in predictive biomarkers for melanoma immunotherapy
Natural killer cell immunotherapy in glioblastoma